http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109928983-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 |
| filingDate | 2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109928983-B |
| titleOfInvention | 2-oxadiazole-3-aminothieno [2,3-b ] pyridine derivative and preparation method and application thereof |
| abstract | The present invention belongs to the field of chemical technologyThe field of medicine, in particular to 2-oxadiazole-3-aminothieno [2,3-b ]]Pyridine derivatives, and preparation methods and uses thereof. The invention provides a 2-oxadiazole-3-aminothieno [2,3-b ]]The pyridine derivative has a structure shown as a formula I. The invention also provides the 2-oxadiazole-3-aminothieno [2,3-b]Pyridine derivatives, their preparation and use. The invention provides 2-oxadiazole-3-aminothieno [2,3-b]The pyridine derivative compound has good HCV (hepatitis C Virus) inhibition effect and simultaneously shows lower cytotoxicity. Provides a new idea for the development of anti-HCV inhibitors. |
| priorityDate | 2015-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.